share_log

標普將強生(JNJ.US)列入負面信用觀察名單

S&P has placed Johnson & Johnson (JNJ.US) on negative credit watch.

AASTOCKS ·  Jan 14 18:31

The rating agency S&P has placed Johnson & Johnson (JNJ.US) on credit watch with a negative outlook, primarily due to the company's investment of nearly 15 billion USD to acquire the mental health drug developer Intra-Cellular Therapies.

S&P believes that this acquisition will increase Johnson & Johnson's adjusted leverage ratio to about 1.4 times, exceeding the downward trigger of 1 time for the S&P rating. Johnson & Johnson added that it expects the adjusted leverage ratio to drop to 1.1 times by the end of 2025 and below 1 time by the end of 2026.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 382

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.